March 2, 2021
Akoya and Johns Hopkins’ Collaborative Agreement Supports Pioneering New Approach to Immunotherapy Biomarker Discovery and Validation
Astronomy and Pathology (AstroPath™) come together for the first time to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence. MARLBOROUGH, Mass. — March 2, 2021   —  Akoya Biosciences, Inc., The Spatial Biology Company®, today announced a...

Continue Reading
January 11, 2021
Akoya Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021
MENLO PARK, Calif. — January 11, 2021  — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced that Brian McKelligon, the company’s Chief Executive Officer, is scheduled to present at the J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021. Mr....

Continue Reading
Displaying 21 - 22 of 22

Search Investor Relations